Compared with PBNs in lung carcinomas patients, increased levels of CCR5, CCR7, CXCR3, and CXCR4 are expressed in TANs, whereas CXCR1 and CXCR2 expression are downregulated [76]. This evidence concerns the gene CXCR4 and lung carcinoma.